Infinity Pharma (INFI) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts INFI Hot Sheet
Join SI Premium – FREE
Infinity Pharma (NASDAQ: INFI) reported Q2 EPS of ($0.12), $0.08 better than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Infinity Pharma (INFI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
